Multi-centre study of acebutolol in hypertensive subjects: results for patients from the 50 to 64-years' old and over 65 years' old age groups.
The results of a multi-centre general practice study on acebutolol in the treatment of hypertension were examined for two age groups of patients, namely those aged from 50 to 64 years and those aged 65 years and over. A total of 1501 patients was studied and followed-up over a period of 3 months. There was a marked reduction in systolic and diastolic blood pressure with treatment and the results, in terms of efficacy and tolerance, were comparable in both age groups. These findings indicate that acebutolol is warranted in the treatment of elderly patients with hypertension.
D000070:Acebutolol / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D000375:Aging; D001794:Blood Pressure; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011674:Pulse; D013997:Time Factors
D000070:Acebutolol